Factor Therapeutics Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Brisbane Australia (2002)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2016
NCT02973893
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Tissue Therapies Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

vitrogro (1 trial)

Drugs in Phase 2 Trials (1)

vf001-dp (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Leg Ulcer (Phase 3)

Pathologic Processes (Phase 2)

Skin Diseases (Phase 2)

Skin Ulcer (Phase 2)

Ulcer (Phase 3)

Varicose Ulcer (Phase 3)

Vascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2